INDICATIONS
BIONECT® is indicated for the dressing and management of partial to full
thickness dermal ulcers (pressure sores, venous stasis ulcers, arterial ulcers,
diabetic ulcers), wounds including cuts, abrasions, donor sites, and post-operative
incisions, irritations of the skin, and first and second degree burns. The dressing
is intended to cover a wound or burn on a patient's skin, and protect against
abrasion, friction, and desiccation.
DOSAGE AND ADMINISTRATION
The wounds or ulcers should be cleaned and disinfected prior to treatment.
In the event of long-standing ulcers, it may be advisable to clean and/or to
debride the wound by surgical or enzymatic means, prior to treatment. Apply
a thin layer of BIONECT® without extensive rubbing onto the wound surface,
two or three times per day. Cover the lesion area with a sterile gauze pad and,
if necessary, with an elastic or compressive bandage.
HOW SUPPLIED
BIONECT® Cream/Gel is supplied in a:
25g tube (Cream) - NDC 68712-007-02
30g tube (Gel) - NDC 68712-008-02
60g (2 - 30g Gel tubes) - NDC 68712-008-03
Storage
Please store BIONECT® at room temperature.
BIONECT® Cream may be stored
for up to 24 months, BIONECT® Gel may be stored for up to 24 months.
Manufactured for: JSJ Pharmaceuticals, Inc. 140 East Bay Street, Charleston,
SC 29401. Toll Free: 1-800-499-4468. Manufactured by: Fidia Farmaceutici S.p.A.
Italy. July 2008